Zepp Health Corporation
ZEPP
$37.96
$0.591.58%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 40.22% | 4.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 40.22% | 4.48% | |||
| Cost of Revenue | 49.15% | 3.86% | |||
| Gross Profit | 27.17% | 5.40% | |||
| SG&A Expenses | 4.67% | 22.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.51% | 8.89% | |||
| Operating Income | 28.71% | -27.09% | |||
| Income Before Tax | -75.93% | -22.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -178.31% | -22.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 212.50% | -20.00% | |||
| Net Income | -178.29% | -22.28% | |||
| EBIT | 28.71% | -27.09% | |||
| EBITDA | 27.49% | -33.41% | |||
| EPS Basic | -179.57% | -23.22% | |||
| Normalized Basic EPS | 1.27% | -- | |||
| EPS Diluted | -179.57% | -23.22% | |||
| Normalized Diluted EPS | 1.27% | -- | |||
| Average Basic Shares Outstanding | -0.45% | -0.77% | |||
| Average Diluted Shares Outstanding | -0.46% | -0.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||